The US Food and Drug Administration has approved a generic oral suspension of a common influenza drug to prevent and treat the virus in adults and children.
The US Food and Drug Administration has approved a generic oral suspension of a common influenza drug to prevent and treat the virus in adults and children.
The US Food and Drug Administration has approved a generic oral suspension of a common influenza drug to prevent and treat the virus in adults and children.
The FDA has approved the first treatment option in the United States for patients age 3 years or older with congenital or idiopathic pulmonary arterial hypertension.
The FDA has approved the first treatment option in the United States for patients age 3 years or older with congenital or idiopathic pulmonary arterial hypertension.
The FDA has approved the first treatment option in the United States for patients age 3 years or older with congenital or idiopathic pulmonary arterial hypertension.